Press Releases
Press Releases
-
May 15, 2019
Kite to Present New Data From Leading Cell Therapy Portfolio at ASCO 2019 -
May 9, 2019
Gilead Sciences to Provide Free Truvada for PrEP® to Support U.S. Initiative to End the HIV Epidemic -
May 8, 2019
Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease -
May 6, 2019
Gilead Sciences to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14 -
May 2, 2019
Gilead Sciences Announces Second Quarter 2019 Dividend -
May 2, 2019
Gilead Sciences Announces First Quarter 2019 Financial Results -
April 30, 2019
Gilead Sciences’ Chief Financial Officer Robin Washington to Step Down in Early 2020 -
April 25, 2019
Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH) -
April 24, 2019
Kite Announces Plans for New State-of-the-Art Facility to Expand Cell Therapy Production Capabilities -
April 18, 2019
Gilead Sciences to Release First Quarter 2019 Financial Results on Thursday, May 2, 2019